20821001), Guangdong Provincial Natural Science Foundation
(No. 9351027501000003), National Basic Research Program of
China (973 Program No. 2007CB815306), and Fundamental
Research Funds for the Central Universities.
Notes and references
1 (a) J. Davis, Angew. Chem., Int. Ed., 2004, 43, 668; (b) J. L. Huppert,
Chem. Soc. Rev., 2008, 37, 1375; (c) S. Balasubramanian and S. Neidle,
Curr. Opin. Chem. Biol., 2009, 13, 345; (d) S. N. Georgiades, N. H. Abd
Karim, K. Suntharalingam and R. Vilar, Angew. Chem. Int. Ed., 2010,
49, 4020.
2 (a) S. Burge, G. N. Parkinson, P. Hazel, A. K. Todd and S. Neidle,
Nucleic Acids Res., 2006, 34, 5402; (b) D. J. Patel, A. T. Phan and V.
Kuryavyi, Nucleic Acids Res., 2007, 35, 7429.
Fig. 2 Effect of complexes 1, 2 and 3 (0–8.0 mM) on the hybridization of
HTG21 in a PCR-stop assay.
PCR product detected at 8.0 mM. But the three ligands hardly
inhibit the appearance of the PCR product (Fig. S3†). This
data also suggest all the complexes are efficient G-quadruplexes
binders. Besides, in order to exclude the possibility of enzyme
inhibition by the ligands and the platinum complexes, the par-
allel experiment was performed using a mutated oligomer (5¢-
GAG[T2AGAG]3-3¢, HTG21 mu) instead of HTG21 in identical
conditions. And the result indicates that these compounds cannot
obviously inhibit the Taq polymerase at comparable concentration
(Fig. S3†).
Finally, Molecular Docking was performed to study the binding
interaction of 2 with human telomeric DNA (PDB code 1KF1)
to gain more structural insights. The data (Fig. 3) indicate that
2 contains a square p-aromatic surface that is in the center of a
terminal G-quartet, with the charged side chains extending into
the groove of the quadruplex. This result implies that multiple
binding modes co-exist between 2 and the quadruplex. Such
results may explain why platinum(II)-triarylpyridines complexes
with positively charged tetraalkylammonium groups are efficient
G-quadruplex binders.
3 A. M. Zahler, J. R. Williamson, T. R. Cech and D. M. Prescott, Nature,
1991, 350, 718.
4 (a) E. M. Rezler, D. J. Rearss and L. H. Hurley, Curr. Opin. Pharmacol.,
2002, 2, 415; (b) P. Alberti, L. Lacroix, L. Guittat, C. Helene and J. L.
Mergny, Mini Rev. Med. Chem., 2003, 3, 23; (c) J. F. Riou, Curr. Med.
Chem. Anticancer Agents, 2004, 4, 439; (d) A. De Cian, L. Lacroix,
C. Douarre, N. Temime-Smaali, C. Trentesaux, J.-F. Riou and J.-L.
Mergny, Biochimie, 2008, 90, 131; (e) D. Monchaud and M.-P. Teulade-
Fichou, Org. Biomol. Chem., 2008, 6, 627; (f) T. M. Ou, Y. J. Lu, J.
H. Tan, Z. S. Huang, K. Y. Wong and L. Q. Gu, Chem Med Chem,
2008, 690; (g) J. L. Huppert, Chem. Soc. Rev., 2008, 37, 1375; (h) S.
Balasubramanian and S. Neidle, Curr. Opin. Chem. Biol., 2009, 13,
345; (i) G. R. Li, J. Huang, M. Zhang, Y. Y. Zhou, D. Zhang, Z. G. Wu,
S. R Wang, X. C. Weng, X. Zhou and G. F. Yang, Chem. Commun.,
2008, 4564; (j) J. Huang, G. R. Li, Z. G. Wu, Z. B. Song, Y. Y. Zhou, L.
Shuai, X. C. Weng, X. Zhou and G. F. Yang, Chem. Commun., 2009,
902.
5 (a) J. E. Reed, A. A. Arnal, S. Neidle and R. Vilar, J. Am. Chem. Soc.,
2006, 128, 5992; (b) N. H. Campbell, M. Patel, A. B. Tofa, R. Ghosh,
G. N. Parkinson and S. Neidle, Biochemistry, 2009, 48, 1675.
6 (a) J. E. Reed, S. Neidle and R. Vilar, Chem. Commun., 2007, 4366;
(b) H. Bertrand, D. Monchaud, A. De Cian, R. Guillot, J.-L. Mergny
and M.-P. Teulade-Fichou, Org. Biomol. Chem., 2007, 5, 2555; (c) R.
Kieltyka, P. Englebienne, J. Fakhoury, C. Autexier, N. Moitessier and
H. F. Sleiman, J. Am. Chem. Soc., 2008, 130, 10040; (d) R. Kieltyka, J.
Fakhoury, N. Moitessier and H. F. Sleiman, Chem. - Eur. J., 2008, 14,
1145; (e) J. Talib, C. Green, K. J. Davis, T. Urathamakul, J. L. Beck,
J. R. Aldrich-Wright and S. F. Ralph, Dalton Trans., 2008, 1018; (f) J.
E. Reed, A. J. P. White, S. Neidle and R. Vilar, Dalton Trans., 2009,
2558; (g) D.-L. Ma, C.-M. Che and S.-C. Yan, J. Am. Chem. Soc., 2009,
131, 1835; (h) H. Bertrand, S. Bombard, D. Monchaud, E. Talbot, A.
Gue´din, J.-L. Mergny, R. Gru¨nert, P. J. Bednarski and M.-P. Teulade-
Fichou, Org. Biomol. Chem., 2009, 7, 2864; (i) J. T. Wang, X. H. Zheng,
Q. Xia, Z. W. Mao, L. N. Ji and K. Wang, Dalton Trans., 2010, 7214.
7 (a) Z. A. E. Waller, P. S. Shirude, R. Rodriguez and S. Balasubramanian,
Chem. Commun., 2008, 1467; (b) Z. A. E. Waller, S. A. Sewitz, S.-T.
Danny Hsu and S. Balasubramanian, J. Am. Chem. Soc., 2009, 131,
12628.
Fig. 3 Predicted interaction between 2 and the intermolecular G-quadru-
plex. The Pt(II) complex is in yellow (shown as a stick and ball model).
8 B. Tang, F. Yu, P. Li, L. Tong, X. Duan, T. Xie and X. Wang, J. Am.
Chem. Soc., 2009, 131, 3016.
9 (a) W. Li, P. Wu, T. Ohmichi and N. Sugimoto, FEBS Lett., 2002, 526,
77; (b) E. M. Rezler, J. Seenisamy, S. Bashyam, M.-Y. Kim, E. White,
W. D. Wilson and L. H. Hurley, J. Am. Chem. Soc., 2005, 127, 9439;
(c) J. L. Zhou, Y. J. Lu, T. M. Ou, J. M. Zhou, Z. S. Huang, X. F. Zhu,
C. J. Du, X. Z. Bu, L. Ma, L. Q. Gu, Y. M. Li and A. S. C. Chan, J.
Med. Chem., 2005, 48, 7315; (d) Y. Xu, Y. Noguchi and H. Sugiyama,
Bioorg. Med. Chem., 2006, 14, 5584.
10 (a) D. Monchaud, P. Yang, L. Lacroix, M.-P. Teulade-Fichou and J.-L.
Mergny, Angew. Chem. Int. Ed., 2008, 47, 4858; (b) K. M. Rahman,
A. P. Reszka, M. Gunaratnam, S. M. Haider, P. W. Howard, K. R.
Fox, S. Neidle and D. E. Thurston, Chem. Commun., 2009, 4097; (c) J.
H. Tan, T. M. Ou, J. Q. Hou, Y. J. Lu, S. L. Huang, H. B. Luo, J. Y.
Wu, Z. S. Huang, K. Y. Wong and L. Q. Gu, J. Med. Chem., 2009, 52,
2825.
In this work, our purpose was to design and evaluate a
series of platinum(II)-triarylpyridines complexes with tetraalky-
lammonium pendants that would show effective binding to G-
quadruplex. All the experimental results clearly show that these
ligands and complexes are capable of inducing the stabilization of
G-quadruplexes, while the complexes are more efficient than their
free ligands. Furthermore, complex 2 exhibits highest stabilization
potential for G-quadruplex due to its appropriate triethylamine
pendant. Our experiments also suggest that Pt(II) complexes could
provide planar p-surfaces that promise them with G-quadruplex
binding potentials, therefore the introduction of proper positively
charged pendants is a practical approach for G-quadruplex binder
design.
11 J.-L. Mergny and J.-C. Maurizot, ChemBioChem, 2001, 2, 124.
12 (a) H. Han, L. H. Hurley and M. A Salazar, Nucleic Acids Res., 1999,
27, 537; (b) T. Lemarteleur, D. Gomez, R. Paterski, E. Mandine, P.
Mailliet and J.-F. Riou, Biochem. Biophys. Res. Commun., 2004, 323,
802.
This work was supported by the National Natural Science
Foundation of China (Nos. 30770494, 20725103, 20831006, and
566 | Dalton Trans., 2011, 40, 564–566
This journal is
The Royal Society of Chemistry 2011
©